Key facts
- It has raised $1.5M; the latest was Seed Round ($1.5M) in Jun 2025.
- Notable investors include Whale Tank.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Utopia Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Utopia Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Utopia Therapeutics
Developer of healthcare vaccines designed through the use of stem cell therapies. The company is producing a novel vaccine designed to reduce fat accumulation and improve metabolic health by targeting lipid-associated antigens, enabling the healthcare sector to support obesity treatment.
- Sector
- Healthcare
- HQ
- Hyderabad, India
- Founded
- 2024
- Employees
- 5
- Ownership
- Privately Held (backing)
Utopia Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Utopia Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Utopia Therapeutics in its N-PORT filings yet. We sweep new filings monthly.